Orgenesis
MD - GermantownBiotechnology
Focus: Orgenesis is a newly founded (2024) biotechnology company specializing in autologous cellular conversion for metabolic diseases, headquartered in Germantown, Maryland. The company is at a very early stage with minimal disclosed operational scale.
Profile data last refreshed 17h ago · AI intelligence enriched 1w ago
Open Jobs
0
About Orgenesis
AI assessmentNot HiringNo open roles listed right now. Follow Orgenesis to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Liver biopsy collection
Type 1 DiabetesClinical Trials (1)
NCT04038931Collection of Human Liver Biopsy and Whole Blood Samples From T1DM, TP or PP Patients for Potential Use for Insulin Producing Cells in Future Clinical Studies
N/AHelp build intelligence for Orgenesis
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.